The Use of Natural Products in the Management of Diabetes: The Current Trends

Natural products have played and continue to play a great role in the management of different diseases. Natural products are usually believed to be safer, cheaper, easily available and sometimes more efficacious than purely synthetic drugs. Diabetes mellitus is a major health problem in the world. There is no cure for diabetes. With the increase in a number of newer drugs for diabetes, there is the possibility of a wide range of side effects that vary from one drug to another.  It is, therefore, essential to practice effective methods of the treatment and management of diabetes. Hence, the need to explore antidiabetic drugs of natural origin with minimal side effects is highly essential. This review provides a scientific perspective on the usage and research of natural traditional remedies in the management of diabetes. The aim of the present review is to provide a comprehensive and concise overview of the previously reported clinical trials of antioxidative natural products in the management of diabetes. Keywords: Diabetes, Natural products, Hyperglycemia, Diabetic complications

Anti-inflammatory and analgesic activities of the aqueous extract of Leonotis leonurus leaves in rats

Leonotis leonurus (L.) R. BR. Lamiaceae is extensively for the treatment of various ailments and in the Eastern Cape province of South Africa, it is used for the treatment of effects of gastrointestinal parasites in animals. There is, however, scanty information on the pharmacological activities of this plant. The aqueous extract from the leaf of L. leonurus was investigated for its analgesic and antiinflammatory properties. Carrageenan and histamine-induced rat paw oedema were conducted to evaluate anti-inflammatory activity, while acetic acid-induced writhing test was conducted to assess the analgesic activity of the plant. The extract was administered intraperitoneally (i.p) to rats at graded doses of 50, 100, 200 mg/kg body weight (BWt). Indomethacin (10 mg/kg BWt) was used as reference drug, whereas the vehicle (2 mg/kg BWt of 0.9% normal saline in Tween-80) was used as negative control. Acute toxicity was tested in rats at doses of 200, 400, 800 and 1600 mg/kg BWt. Compared with the control, the plant extract at 100 and 200 mg/kg BWt significantly (P < 0.05) reduced the formation of carrageenan - induced oedema, while with histamine-induced oedema the difference was insignificant (P > 0.05). In the acetic acid-induced writhing model, the plant extract produced a significant (P < 0.05) reduction in the number of writhes with all test doses and at 100 and 200 mg/kg BWt, the extract produced results that were similar to those of Indomethacin. This study revealed the potential of L. leonurus leaf aqueous extract in reducing pain and inflammation, suggesting that it has some antiinflammatory and analgesic activities, hence, justifying its ethno-veterinary uses. The acute toxicity test showed that the plant is relatively safe to use.Key words: Analgesic, anti-inflammation, indomethacin, Leonotis leonurus, rats

Evaluation of free-radical quenching properties of standard Ayurvedic formulation Vayasthapana Rasayana

<p>Abstract</p> <p>Background</p> <p>Cellular damage induced by free-radicals like Reactive Oxygen and Nitrogen Species (ROS and RNS) has been implicated in several disorders and diseases, including ageing. Hence naturally occurring anti-oxidant rich-herbs play a vital role in combating these conditions. The present study was carried out to investigate the <it>in vitro </it>free-radical quenching capacity of a known <it>Ayurvedic </it>poly-herbal formulation called <it>Vayasthapana Rasayana.</it></p> <p>Methods</p> <p>Methanol extracts of <it>Vayasthapana Rasayana </it>formulation (VRF) were studied for <it>in vitro </it>total antioxidant activity along with phenolic content and reducing power. <it>In vitro </it>assays like DPPH, FRAP, ABTS scavenging to evaluate radical quenching potential were performed.</p> <p>Results</p> <p>The formulation has shown 94% at 0.1 mg/ml DPPH free-radical scavenging activity as against 84% at 0.1 mg/ml for standard ascorbic acid (IC₅₀value 5.51 μg/ml for VRF and 39 μg/ml for standard). It has a significant higher ferric reducing potential also (OD 0.87 at 700 nm & 0.21 at 0.1 mg/ml for VRF and standard, respectively). The total phenolic content (gallic acid equivalent) of the VRF is 8.3 mg per g of dry mass. Total antioxidant capacity of the formulation, estimated by FRAP was 1150 ± 5 μM Fe(II)/g dry mass. ABTS radical scavenging activity of VRF was 69.55 ± 0.21% at 100 μg/ml concentration with a IC₅₀value of 69.87 μg/ml as against 9% and 95% by ascorbic acid and Trolox (at 70.452 μg/ml and 0.250 μg/ml concentrations, respectively).</p> <p>Conclusion</p> <p>In Indian traditional <it>Ayurvedic </it>system, use of VRF is in regular practice for mainly combating age-related disorders and diseases as many of the components of the <it>Rasayana </it>are known for their free-radical scavenging activity. This study has validated the potential use of VRF as an anti-oxidant to fight age-related problems.</p

Phytochemical studies and antioxidant activity of two South African medicinal plants traditionally used for the management of opportunistic fungal infections in HIV/AIDS patients

<p>Abstract</p> <p>Background</p> <p>It has been observed that perturbations in the antioxidant defense systems, and consequently redox imbalance, are present in many tissues of HIV-infected patients. Hence, the exogenous supply of antioxidants, as natural compounds that scavenge free radicals, might represent an important additional strategy for the treatment of HIV infection. The aim of this study was therefore to analyse the phytochemical constituents and antioxidant potential of <it>Gasteria bicolor </it>Haw and <it>Pittosporum viridiflorum </it>Sims., two South African plants traditionally used for the management of opportunistic fungal infections (OFIs) in AIDS patients.</p> <p>Methods</p> <p>The <it>in vitro </it>antioxidant properties of the two plants were screened through DPPH (1,1-diphenyl-2-picrylhydrazyl), NO (nitric oxide), H₂O₂(hydrogen peroxide) radical scavenging effects and reducing power assays. Phytochemical studies were done by spectrophotometric techniques.</p> <p>Results</p> <p>There were no significant differences in the flavonoid and proanthocyanidins contents between the leaves and bark extracts of <it>Gasteria bicolor </it>and <it>Pittosporum viridiflorum </it>respectively, while the total phenolic content of the bark extract of <it>P. viridiflorum </it>was significantly higher than that of <it>G. bicolor </it>leaf. The acetone extracts of both plants indicated strong antioxidant activities.</p> <p>Conclusion</p> <p>The results from this study indicate that the leaves and stem extracts of <it>Gasteria bicolor </it>and <it>Pittosporum viridiflorum </it>respectively possess antioxidant properties and could serve as free radical inhibitors, acting possibly as primary antioxidants. Since reactive oxygen species are thought to be associated with the pathogenesis of AIDS, and HIV-infected individuals often have impaired antioxidant defenses, the inhibitory effect of the extracts on free radicals may partially justify the traditional use of these plants in the management of OFIs in HIV patients in South Africa.</p

Blechnum Orientale Linn - a fern with potential as antioxidant, anticancer and antibacterial agent

<p>Abstract</p> <p>Background</p> <p><it>Blechnum orientale </it>Linn. (<it>Blechnaceae</it>) is used ethnomedicinally for the treatment of various skin diseases, stomach pain, urinary bladder complaints and sterilization of women. The aim of the study was to evaluate antioxidant, anticancer and antibacterial activity of five solvent fractions obtained from the methanol extract of the leaves of <it>Blechnum orientale </it>Linn.</p> <p>Methods</p> <p>Five solvent fractions were obtained from the methanol extract of <it>B. orientale</it> through successive partitioning with petroleum ether, chloroform, ethyl acetate, butanol and water. Total phenolic content was assessed using Folin-Ciocalteu's method. The antioxidant activity was determined by measuring the scavenging activity of DPPH radicals. Cytotoxic activity was tested against four cancer cell lines and a non-malignant cell using MTT assay. Antibacterial activity was assessed using the disc diffusion and broth microdilution assays. Standard phytochemical screening tests for saponins, tannins, terpenoids, flavonoids and alkaloids were also conducted.</p> <p>Results</p> <p>The ethyl acetate, butanol and water fractions possessed strong radical scavenging activity (IC₅₀8.6-13.0 μg/ml) and cytotoxic activity towards human colon cancer cell HT-29 (IC₅₀27.5-42.8 μg/ml). The three extracts were also effective against all Gram-positive bacteria tested: <it>Bacillus cereus, Micrococcus luteus</it>, methicillin-susceptible <it>Staphylococcus aureus </it>(MSSA), methicillin-resistant <it>Staphylococcus aureus </it>(MRSA) and <it>Stapylococcus epidermidis</it>(minimum inhibitory concentration MIC 15.6-250 μg/ml; minimum bactericidal concentration MBC 15.6-250 μg/ml). Phytochemical analysis revealed the presence of flavonoids, terpenoids and tannins. Ethyl acetate and butanol fractions showed highest total phenolic content (675-804 mg gallic acid equivalent/g).</p> <p>Conclusions</p> <p>The results indicate that this fern is a potential candidate to be used as an antioxidant agent, for colon cancer therapy and for treatment of MRSA infections and other MSSA/Gram-positive bacterial infectious diseases.</p

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

Evaluation of the antimicrobial activity of crude extracts and chromatographic fractions of Adenanthera pavonina Linn (Leguminosae) seeds

Most available reports on the biological activity of Adenanthera pavonina (AP) are on the bark or leaves and very few are on the seeds. In particular, there are no reports on the biological effects of the chromatographic fractions of A. pavonina seeds hence the present study aimed to evaluate the antimicrobial activity of the crude extract and chromatographic fractions of A. pavonina seeds. The methanolic extract was fractionated and all of the column chromatographic fractions as well as the crude extract were evaluated against different strains of Staphylococcus aureus. The methanolic extract (100 mg/ml) produced zones of inhibition on PHM 002 and PHM 005 while the 50 and 100 mg/ml of the hexane extract only produced inhibition on PHM 001. On the other hand, fractions ST 10-12 F exhibited activity PHM 002 at 50 and 100 mg/ml while fractions ST-13-15F exhibited activity at all concentrations (6.25, 12.5 25, 50 and 100 mg/ ml) against S. aureus PHM 002 strain from the skin. The study provides some justifications for the folkloric use of AP seed powder as an antiseptic paste and warrants further studies to determine the structure of the active compound in chromatographic fraction ST 13 -15F.Key words: Adenanthera pavonina, antimicrobial activity, chromatographic fractions, methanolic extract

The impact of anticoccidial drug resistance on poultry production - a review

The use of drugs to combat or control infectious organisms is one of the greatest advancements that scientific knowledge has brought to mankind. However, the continued use of a particular drug to control infection is fraught with a lot of dangers, one of which is drug resistance by the infectious organisms to this drug. The implication of this is that the organism is no longer responsive to this drug and hence, there is high morbidity, motality and in fact, there is high economic loss in livestock industry as a result of drug resistance. This review, using coccidiosis and anticoccidial drug resistance highlighted the economic impact of drug resistance on livestock industry but also suggested ways of preventing or minimizing drug resistance on the farm. This way, economic loss will be minimized and more protein from animal origin will be made available to the Nigerian populace. Keywords: drug resistance, coccidiosis, anticoccidial, shuttling Moor Journal of Agricultural Research Vol. 5(2) 2004: 188-19

Cadmium, an Environmental Pollutant: A Review

Cadmium (Cd) is a toxic heavy metal and is considered to be an environmental pollutant. Cadmium levels in the environment vary widely. Several sources of human exposure to Cd, including employment in primary metal industries, production of certain batteries, foods, soil and cigarette smoke, are known. Its inhalation has been related to different respiratory diseases and toxic effects, among which alterations of the physiological redox state in individuals exposed to the metal, have been described. Host-cell redox changes characteristic of oxidative stress facilitate the progression of viral infection through different mechanisms. Cadmium emissions to the environment are normally transported continually between the three main environmental compartments, air, water and soils, but a steady state flux is probably achieved and the general levels can reasonably well be established. The main sources of cadmium in the air are the burning of fossil fuels such as coal or oil and the incineration of municipal waste. The acute (short-term) effects of cadmium in humans through inhalation exposure consist mainly of effects on the lung, such as pulmonary irritation. Chronic (long-term) inhalation or oral exposure to cadmium leads to a build-up of cadmium in the kidneys that can cause kidney disease. Cadmium has been shown to be a developmental toxicant in animals, resulting in fetal malformations and other effects, but no conclusive evidence exists in humans. An association between cadmium exposure and an increased risk of lung cancer has been reported from human studies, but these studies are inconclusive due to confounding factors. Animal studies have demonstrated an increase in lung cancer from long-term inhalation exposure to cadmium. EPA has classified cadmium as a Group B1, probable human carcinogen. This paper is a review of the toxic nature of this metal.Keywords: Cadmium, environment, pollution, cance